Precigen, Inc. (PGEN) income statement
PGENNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 2/30
$4.27−0.02 (-0.47%)
Close on Nov 18, 2026Market cap $1.53BP/E –Yield –
Precigen, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, FY2025
- Gross margin
- –
- Operating margin
- -1141.1%
- Net margin
- -1628.5%
- Return on equity, FY2025
- -843.6%
Financial strength
- Current ratio
- 4.58
- Debt to equity
- 2.15
- Debt to assets
- 55.1%
- Cash to current liabilities
- 55.6%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 35.08
- Dividend yield
- –
See a number that looks wrong?